logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Jump to: Company in focus, Offsprings
Parent entities and officers 6
  • 1
    Selamoglu, Mehmet Levent
    Born in September 1959
    Individual (3 offsprings)
    Officer
    2021-01-20 ~ now
    OF - Director → CIF 0
  • 2
    Kaye, Steven Jonathan
    Born in September 1965
    Individual (14 offsprings)
    Officer
    2021-02-02 ~ now
    OF - Director → CIF 0
  • 3
    Samson, Marvin Stanley
    Born in June 1941
    Individual (1 offspring)
    Officer
    2021-02-02 ~ now
    OF - Director → CIF 0
  • 4
    Mr Joseph Ensink
    Born in April 1964
    Individual (47 offsprings)
    Person with significant control
    2024-07-25 ~ now
    PE - Ownership of shares – More than 50% but less than 75% → CIF 0
    2021-03-18 ~ 2024-03-05
    PE - Ownership of shares – More than 50% but less than 75% → CIF 0
  • 5
    Naidoo, Kiren Lee
    Born in June 1985
    Individual (3 offsprings)
    Officer
    2021-01-20 ~ now
    OF - Director → CIF 0
    Mr Kiren Lee Naidoo
    Born in June 1985
    Individual (3 offsprings)
    Person with significant control
    2021-01-20 ~ 2024-03-05
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Ownership of shares – 75% or more → CIF 0
  • 6
    FRONTIER PHARMA LIMITED
    10130529 13146422
    Kemp House, 160 City Road, London, United Kingdom
    Active Corporate (3 parents, 1 offspring)
    Person with significant control
    2021-02-02 ~ now
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
parent relation
Company in focus

FRONTIER BIOPHARMA LIMITED

Period: 2023-09-07 ~ now
Company number: 13146422 10130529
Registered names
FRONTIER BIOPHARMA LIMITED - now 10130529
Standard Industrial Classification
64202 - Activities Of Production Holding Companies
Brief company account
Total Borrowings
6,813,811 GBP2024-12-31
3,444,295 GBP2023-12-31
Audit Fees/Expenses
26,000 GBP2023-01-01 ~ 2023-12-31
Tax Expense/Credit at Applicable Tax Rate
-382,065 GBP2024-01-01 ~ 2024-12-31
-519,577 GBP2023-01-01 ~ 2023-12-31
Intangible Assets - Accumulated Amortisation & Impairment
2,553,477 GBP2024-12-31
1,827,657 GBP2023-12-31
Intangible Assets - Increase From Amortisation Charge for Year
737,775 GBP2024-01-01 ~ 2024-12-31
Property, Plant & Equipment - Other Disposals
-215,838 GBP2024-01-01 ~ 2024-12-31
-93,947 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
6,817,627 GBP2024-12-31
5,672,311 GBP2023-12-31
3,877,007 GBP2022-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
1,360,881 GBP2024-01-01 ~ 2024-12-31
1,877,124 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Other Disposals/Decrease in Depreciation & Impairment
-215,565 GBP2024-01-01 ~ 2024-12-31
-81,820 GBP2023-01-01 ~ 2023-12-31
Other Taxation & Social Security Payable
Current
72,295 GBP2024-12-31
58,146 GBP2023-12-31
Cash and Cash Equivalents
27,404 GBP2024-12-31
25,553 GBP2023-12-31
322 GBP2022-12-31
Total Borrowings
Current
0 GBP2024-12-31
445,559 GBP2023-12-31
Non-current
4,332,172 GBP2024-12-31
3,823,126 GBP2023-12-31
Equity
Called up share capital
1,731,526 GBP2024-12-31
1,731,526 GBP2023-12-31
1,731,526 GBP2022-12-31
Retained earnings (accumulated losses)
-1,662,902 GBP2024-12-31
-1,095,454 GBP2023-12-31
Equity
68,624 GBP2024-12-31
636,072 GBP2023-12-31
-667,920 GBP2022-12-31
Profit/Loss
Retained earnings (accumulated losses)
-567,448 GBP2024-01-01 ~ 2024-12-31
-427,534 GBP2023-01-01 ~ 2023-12-31
Average Number of Employees
12024-01-01 ~ 2024-12-31
12023-01-01 ~ 2023-12-31
Wages/Salaries
169,000 GBP2024-01-01 ~ 2024-12-31
104,108 GBP2023-01-01 ~ 2023-12-31
Pension & Other Post-employment Benefit Costs/Other Pension Costs
6,700 GBP2024-01-01 ~ 2024-12-31
5,205 GBP2023-01-01 ~ 2023-12-31
Staff Costs/Employee Benefits Expense
197,767 GBP2024-01-01 ~ 2024-12-31
122,738 GBP2023-01-01 ~ 2023-12-31
Trade Debtors/Trade Receivables
Current
79,572 GBP2024-12-31
0 GBP2023-12-31
Prepayments
25,836 GBP2024-12-31
Current
0 GBP2023-12-31
Trade Creditors/Trade Payables
Current
75,538 GBP2024-12-31
20,337 GBP2023-12-31
Non-current
0 GBP2024-12-31
0 GBP2023-12-31
Accrued Liabilities
Current
38,000 GBP2024-12-31
75,500 GBP2023-12-31
Other Interest Receivable/Similar Income (Finance Income)
-78,349 GBP2024-01-01 ~ 2024-12-31
-4,576 GBP2023-01-01 ~ 2023-12-31
  • FRONTIER BIOPHARMA LIMITED
    Info
    DRINA HOLDINGS LIMITED - 2023-09-07
    Registered number 13146422
    C/o Flb Accountants Llp 1010 Eskdale Road, Winnersh Triangle, Wokingham RG41 5TS
    PRIVATE LIMITED COMPANY incorporated on 2021-01-20 (5 years 3 months). The status of the company number is Active.
    The last date of confirmation statement was made at 2026-01-19
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 5 April 2026 and licensed under the Open Government Licence v3.0.